Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Millet Innovation is a French healthcare company specializing in the development and commercialization of orthopedic and podiatry products, primarily under the brand name Epitact. Founded by Harry Millet, the company is renowned for its proprietary silicone gel technology, which is used to create ergonomic supports and protections for joints and skin. Its product portfolio addresses common conditions such as hallux valgus (bunions), knee osteoarthritis, and carpal tunnel syndrome, providing non-invasive therapeutic solutions. The company's products are widely distributed through pharmacies and specialized medical retailers across Europe. In 2021, Millet Innovation was acquired by the Urgo Group, a major international healthcare player, to enhance its orthopedic and compression therapy offerings.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on H. Millet.